activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	400249	CHEMBL662980	Ex vivo inhibitory activity against human choline kinase was determined	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2cc(C[n+]3ccc(N(C)c4ccc(Cl)cc4)cc3)cc(C[n+]3ccc(N(C)c4ccc(Cl)cc4)cc3)c2)cc1.[Br-].[Br-].[Br-]		CHEMBL332621	=	IC50	nM	1400.0	CHEMBL3117	Homo sapiens	IC50	uM	1.4
	400249	CHEMBL662980	Ex vivo inhibitory activity against human choline kinase was determined	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2cc(C[n+]3ccc(N(C)c4ccc(Cl)cc4)cc3)cc(C[n+]3ccc(N(C)c4ccc(Cl)cc4)cc3)c2)cc1.[Br-].[Br-].[Br-]		CHEMBL332621	=	IC50	nM	1400.0	CHEMBL3117	Homo sapiens	IC50	uM	1.4
	405924	CHEMBL662980	Ex vivo inhibitory activity against human choline kinase was determined	B	[Br-].[Br-].c1cc2cc(c1)CNc1cc[n+](cc1)Cc1ccc(cc1)C[n+]1ccc(cc1)NC2		CHEMBL125148	=	IC50	nM	300.0	CHEMBL3117	Homo sapiens	IC50	uM	0.3
	412065	CHEMBL662980	Ex vivo inhibitory activity against human choline kinase was determined	B	[Br-].[Br-].c1cc2cc(c1)C[n+]1ccc(cc1)NCc1ccc(cc1)CNc1cc[n+](cc1)C2		CHEMBL341537	=	IC50	nM	24800.0	CHEMBL3117	Homo sapiens	IC50	uM	24.8
	427194	CHEMBL662980	Ex vivo inhibitory activity against human choline kinase was determined	B	[Br-].[Br-].c1cc2ccc1CNc1cc[n+](cc1)Cc1ccc(cc1)C[n+]1ccc(cc1)NC2		CHEMBL125434	=	IC50	nM	2100.0	CHEMBL3117	Homo sapiens	IC50	uM	2.1
	429710	CHEMBL662980	Ex vivo inhibitory activity against human choline kinase was determined	B	[Br-].[Br-].c1cc2cc(c1)CNc1cc[n+](cc1)Cc1cccc(c1)C[n+]1ccc(cc1)NC2		CHEMBL121973	=	IC50	nM	13200.0	CHEMBL3117	Homo sapiens	IC50	uM	13.2
	517493	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	N#Cc1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(C#N)cc4)cc3)cc2)cc1.[Br-].[Br-]	Outside typical range	CHEMBL349401	>	IC50	nM	1000000.0	CHEMBL3117	Homo sapiens	IC50	uM	1000.0
	522744	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	Cc1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(C)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL349948	=	IC50	nM	100000.0	CHEMBL3117	Homo sapiens	IC50	uM	100.0
	525327	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	C=CCN(CC=C)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(CC=C)CC=C)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL166190	=	IC50	nM	17000.0	CHEMBL3117	Homo sapiens	IC50	uM	17.0
	528026	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	O=C(O)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(C(=O)O)cc4)cc3)cc2)cc1.[Br-].[Br-]	Outside typical range	CHEMBL165570	=	IC50	nM	136700.0	CHEMBL3117	Homo sapiens	IC50	uM	136.7
	528042	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCC3)cc2)ccc1CCc1ccc(C[n+]2ccc(N3CCCCC3)cc2)cc1		CHEMBL163319	=	IC50	nM	9600.0	CHEMBL3117	Homo sapiens	IC50	uM	9.6
	534764	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	OCc1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(CO)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL165437	=	IC50	nM	100000.0	CHEMBL3117	Homo sapiens	IC50	uM	100.0
	536089	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	Nc1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL164858	=	IC50	nM	23000.0	CHEMBL3117	Homo sapiens	IC50	uM	23.0
	543896	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	CN(C)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(C)C)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL164903	=	IC50	nM	17000.0	CHEMBL3117	Homo sapiens	IC50	uM	17.0
	546554	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCCC3)cc2)ccc1CCc1ccc(C[n+]2ccc(N3CCCCCC3)cc2)cc1		CHEMBL164952	=	IC50	nM	15000.0	CHEMBL3117	Homo sapiens	IC50	uM	15.0
	552593	CHEMBL662981	Compound was tested ex vivo for inhibition against purified choline kinase obtained from yeast	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCC3)cc2)ccc1CCc1ccc(C[n+]2ccc(N3CCCC3)cc2)cc1		CHEMBL350410	=	IC50	nM	20000.0	CHEMBL3117	Homo sapiens	IC50	uM	20.0
	1471523	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1c[n+](C[C@H]2C[C@@H]2C[n+]2ccc(N3CCCC3)cc2)ccc1N1CCCC1		CHEMBL184576	>	IC50	nM	100000.0	CHEMBL3117	Homo sapiens	IC50	uM	100.0
	1471525	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1c[n+](C[C@H]2C[C@@H]2C[n+]2ccc(N3CCCCC3)cc2)ccc1N1CCCCC1		CHEMBL365193	=	IC50	nM	98000.0	CHEMBL3117	Homo sapiens	IC50	uM	98.0
	1471527	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccccc1)c1cc[n+](C[C@H]2C[C@@H]2C[n+]2ccc(N(C)c3ccccc3)cc2)cc1.[Br-].[Br-]		CHEMBL364174	>	IC50	nM	100000.0	CHEMBL3117	Homo sapiens	IC50	uM	100.0
	1471529	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccc(Cl)cc1)c1cc[n+](C[C@H]2C[C@@H]2C[n+]2ccc(N(C)c3ccc(Cl)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL185961	=	IC50	nM	48200.0	CHEMBL3117	Homo sapiens	IC50	uM	48.2
	1471531	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1cc[n+](C[C@H]2C[C@@H]2C[n+]2ccc(N(C)c3cc(Cl)cc(Cl)c3)cc2)cc1)c1cc(Cl)cc(Cl)c1.[Br-].[Br-]		CHEMBL189334	>	IC50	nM	100000.0	CHEMBL3117	Homo sapiens	IC50	uM	100.0
	1471533	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCC3)cc2)cc(C[n+]2ccc(N3CCCC3)cc2)c1		CHEMBL188935	=	IC50	nM	84200.0	CHEMBL3117	Homo sapiens	IC50	uM	84.2
	1471535	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCC3)cc2)cc(C[n+]2ccc(N3CCCCC3)cc2)c1		CHEMBL186589	=	IC50	nM	52800.0	CHEMBL3117	Homo sapiens	IC50	uM	52.8
	1471537	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccccc1)c1cc[n+](Cc2cccc(C[n+]3ccc(N(C)c4ccccc4)cc3)c2)cc1.[Br-].[Br-]		CHEMBL186168	=	IC50	nM	37500.0	CHEMBL3117	Homo sapiens	IC50	uM	37.5
	1471539	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2cccc(C[n+]3ccc(N(C)c4ccc(Cl)cc4)cc3)c2)cc1.[Br-].[Br-]		CHEMBL188936	=	IC50	nM	7200.0	CHEMBL3117	Homo sapiens	IC50	uM	7.2
	1471541	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1cc[n+](Cc2cccc(C[n+]3ccc(N(C)c4cc(Cl)cc(Cl)c4)cc3)c2)cc1)c1cc(Cl)cc(Cl)c1.[Br-].[Br-]		CHEMBL187655	=	IC50	nM	8400.0	CHEMBL3117	Homo sapiens	IC50	uM	8.4
	1471543	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCC3)cc2)ccc1C[n+]1ccc(N2CCCC2)cc1		CHEMBL434153	=	IC50	nM	24000.0	CHEMBL3117	Homo sapiens	IC50	uM	24.0
	1471545	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCC3)cc2)ccc1C[n+]1ccc(N2CCCCC2)cc1		CHEMBL188821	=	IC50	nM	37700.0	CHEMBL3117	Homo sapiens	IC50	uM	37.7
	1471547	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(C[n+]3ccc(N(C)c4ccccc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL189567	=	IC50	nM	15000.0	CHEMBL3117	Homo sapiens	IC50	uM	15.0
	1471549	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(C[n+]3ccc(N(C)c4ccc(Cl)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL189761	=	IC50	nM	2900.0	CHEMBL3117	Homo sapiens	IC50	uM	2.9
	1471551	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1cc[n+](Cc2ccc(C[n+]3ccc(N(C)c4cc(Cl)cc(Cl)c4)cc3)cc2)cc1)c1cc(Cl)cc(Cl)c1.[Br-].[Br-]		CHEMBL187601	=	IC50	nM	9700.0	CHEMBL3117	Homo sapiens	IC50	uM	9.7
	1471553	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCC3)cc2)cc(-c2cccc(C[n+]3ccc(N4CCCC4)cc3)c2)c1		CHEMBL186078	=	IC50	nM	5800.0	CHEMBL3117	Homo sapiens	IC50	uM	5.8
	1471555	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCC3)cc2)cc(-c2cccc(C[n+]3ccc(N4CCCCC4)cc3)c2)c1		CHEMBL187404	=	IC50	nM	1900.0	CHEMBL3117	Homo sapiens	IC50	uM	1.9
	1471557	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccccc1)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)c5ccccc5)cc4)c3)c2)cc1.[Br-].[Br-]		CHEMBL364145	=	IC50	nM	400.0	CHEMBL3117	Homo sapiens	IC50	uM	0.4
	1471559	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)cc4)c3)c2)cc1.[Br-].[Br-]		CHEMBL364361	=	IC50	nM	1500.0	CHEMBL3117	Homo sapiens	IC50	uM	1.5
	1471561	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	Clc1cc(Cl)cc(-c2cc[n+](Cc3cccc(-c4cccc(C[n+]5ccc(-c6cc(Cl)cc(Cl)c6)cc5)c4)c3)cc2)c1.[Br-].[Br-]		CHEMBL266946	=	IC50	nM	2600.0	CHEMBL3117	Homo sapiens	IC50	uM	2.6
	1471672	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(-c2ccc(C[n+]3ccc(N4CCCC4)cc3)cc2)ccc1C[n+]1ccc(N2CCCC2)cc1		CHEMBL364654	=	IC50	nM	11100.0	CHEMBL3117	Homo sapiens	IC50	uM	11.1
	1471674	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	[Br-].[Br-].c1cc(-c2ccc(C[n+]3ccc(N4CCCCC4)cc3)cc2)ccc1C[n+]1ccc(N2CCCCC2)cc1		CHEMBL186136	=	IC50	nM	8800.0	CHEMBL3117	Homo sapiens	IC50	uM	8.8
	1471676	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccccc5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL189860	=	IC50	nM	4300.0	CHEMBL3117	Homo sapiens	IC50	uM	4.3
	1471678	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL185999	=	IC50	nM	1800.0	CHEMBL3117	Homo sapiens	IC50	uM	1.8
	1471680	CHEMBL828518	Inhibitory activity against human choline kinase enzyme	B	Clc1cc(Cl)cc(-c2cc[n+](Cc3ccc(-c4ccc(C[n+]5ccc(-c6cc(Cl)cc(Cl)c6)cc5)cc4)cc3)cc2)c1.[Br-].[Br-]		CHEMBL363060	=	IC50	nM	3400.0	CHEMBL3117	Homo sapiens	IC50	uM	3.4
	1506764	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Nc1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N)c5ccccc54)c3)c2)c2ccccc12.[Br-].[Br-]		CHEMBL370057	=	IC50	nM	1200.0	CHEMBL3117	Homo sapiens	IC50	uM	1.2
	1506766	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c[n+](Cc2cccc(-c3cccc(C[n+]4cc(C)c(N)c5ccccc54)c3)c2)c2ccccc2c1N.[Br-].[Br-]		CHEMBL365345	=	IC50	nM	11900.0	CHEMBL3117	Homo sapiens	IC50	uM	11.9
	1506768	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(C)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)C)c5ccccc54)c3)c2)c2ccccc12.[Br-].[Br-]		CHEMBL370712	=	IC50	nM	4400.0	CHEMBL3117	Homo sapiens	IC50	uM	4.4
	1506770	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	[Br-].[Br-].c1cc(C[n+]2ccc(N3CCCCCC3)c3ccccc32)cc(-c2cccc(C[n+]3ccc(N4CCCCCC4)c4ccccc43)c2)c1		CHEMBL372667	=	IC50	nM	500.0	CHEMBL3117	Homo sapiens	IC50	uM	0.5
	1506772	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	[Br-].[Br-].c1ccc(Nc2cc[n+](Cc3cccc(-c4cccc(C[n+]5ccc(Nc6ccccc6)c6ccccc65)c4)c3)c3ccccc23)cc1		CHEMBL191873	=	IC50	nM	1300.0	CHEMBL3117	Homo sapiens	IC50	uM	1.3
	1506774	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccccc1)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)c5ccccc5)c5ccccc54)c3)c2)c2ccccc12.[Br-].[Br-]		CHEMBL191595	=	IC50	nM	400.0	CHEMBL3117	Homo sapiens	IC50	uM	0.4
	1506776	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccccc54)c3)c2)c2ccccc12.[Br-].[Br-]		CHEMBL372448	=	IC50	nM	2100.0	CHEMBL3117	Homo sapiens	IC50	uM	2.1
	1506778	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Nc1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL370040	=	IC50	nM	81100.0	CHEMBL3117	Homo sapiens	IC50	uM	81.1
	1506780	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c[n+](Cc2ccc(-c3ccc(C[n+]4cc(C)c(N)c5ccccc54)cc3)cc2)c2ccccc2c1N.[Br-].[Br-]	Outside typical range	CHEMBL364075	>	IC50	nM	200000.0	CHEMBL3117	Homo sapiens	IC50	uM	200.0
	1506782	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(C)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)C)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL192105	=	IC50	nM	39700.0	CHEMBL3117	Homo sapiens	IC50	uM	39.7
	1506784	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	[Br-].[Br-].c1ccc2c(c1)c(N1CCCCCC1)cc[n+]2Cc1ccc(-c2ccc(C[n+]3ccc(N4CCCCCC4)c4ccccc43)cc2)cc1		CHEMBL366224	=	IC50	nM	2200.0	CHEMBL3117	Homo sapiens	IC50	uM	2.2
	1506786	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	[Br-].[Br-].c1ccc(Nc2cc[n+](Cc3ccc(-c4ccc(C[n+]5ccc(Nc6ccccc6)c6ccccc65)cc4)cc3)c3ccccc23)cc1		CHEMBL192874	=	IC50	nM	17800.0	CHEMBL3117	Homo sapiens	IC50	uM	17.8
	1506788	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccccc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL436108	=	IC50	nM	3000.0	CHEMBL3117	Homo sapiens	IC50	uM	3.0
	1506790	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL192986	=	IC50	nM	2000.0	CHEMBL3117	Homo sapiens	IC50	uM	2.0
	1506913	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Nc1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL362961	=	IC50	nM	80000.0	CHEMBL3117	Homo sapiens	IC50	uM	80.0
	1506915	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(C)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(C)C)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL192987	=	IC50	nM	10200.0	CHEMBL3117	Homo sapiens	IC50	uM	10.2
	1506918	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	[Br-].[Br-].c1ccc2c(c1)c(N1CCCCCC1)cc[n+]2Cc1ccc(CCc2ccc(C[n+]3ccc(N4CCCCCC4)c4ccccc43)cc2)cc1		CHEMBL363853	=	IC50	nM	600.0	CHEMBL3117	Homo sapiens	IC50	uM	0.6
	1506920	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	[Br-].[Br-].c1ccc(Nc2cc[n+](Cc3ccc(CCc4ccc(C[n+]5ccc(Nc6ccccc6)c6ccccc65)cc4)cc3)c3ccccc23)cc1		CHEMBL364022	=	IC50	nM	2300.0	CHEMBL3117	Homo sapiens	IC50	uM	2.3
	1506922	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(C)c5ccccc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL364023	=	IC50	nM	1400.0	CHEMBL3117	Homo sapiens	IC50	uM	1.4
	1506924	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL372223	=	IC50	nM	4800.0	CHEMBL3117	Homo sapiens	IC50	uM	4.8
	1506926	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Nc1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N)c5ccc(Cl)cc54)c3)c2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL191818	=	IC50	nM	20600.0	CHEMBL3117	Homo sapiens	IC50	uM	20.6
	1506928	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(C)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)C)c5ccc(Cl)cc54)c3)c2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL193153	=	IC50	nM	9600.0	CHEMBL3117	Homo sapiens	IC50	uM	9.6
	1506930	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3cccc(-c4cccc(C[n+]5ccc(N6CCCC6)c6ccc(Cl)cc65)c4)c3)c2c1.[Br-].[Br-]		CHEMBL189324	=	IC50	nM	1200.0	CHEMBL3117	Homo sapiens	IC50	uM	1.2
	1506932	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccccc1)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)c5ccccc5)c5ccc(Cl)cc54)c3)c2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL364425	=	IC50	nM	3100.0	CHEMBL3117	Homo sapiens	IC50	uM	3.1
	1506934	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2cccc(-c3cccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccc(Cl)cc54)c3)c2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL364692	=	IC50	nM	5700.0	CHEMBL3117	Homo sapiens	IC50	uM	5.7
	1506936	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Nc1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL192631	=	IC50	nM	63300.0	CHEMBL3117	Homo sapiens	IC50	uM	63.3
	1506938	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(C)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)C)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL363612	=	IC50	nM	20600.0	CHEMBL3117	Homo sapiens	IC50	uM	20.6
	1506940	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccc(-c4ccc(C[n+]5ccc(N6CCCC6)c6ccc(Cl)cc65)cc4)cc3)c2c1.[Br-].[Br-]		CHEMBL364314	=	IC50	nM	19800.0	CHEMBL3117	Homo sapiens	IC50	uM	19.8
	1506942	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccccc5)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL192091	=	IC50	nM	11400.0	CHEMBL3117	Homo sapiens	IC50	uM	11.4
	1506944	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL192063	=	IC50	nM	11400.0	CHEMBL3117	Homo sapiens	IC50	uM	11.4
	1506946	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Nc1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]	Outside typical range	CHEMBL371151	>	IC50	nM	200000.0	CHEMBL3117	Homo sapiens	IC50	uM	200.0
	1506948	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(C)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(C)C)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL372473	=	IC50	nM	9000.0	CHEMBL3117	Homo sapiens	IC50	uM	9.0
	1506951	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccc(CCc4ccc(C[n+]5ccc(N6CCCC6)c6ccc(Cl)cc65)cc4)cc3)c2c1.[Br-].[Br-]		CHEMBL370289	=	IC50	nM	1000.0	CHEMBL3117	Homo sapiens	IC50	uM	1.0
	1507056	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(C)c5ccccc5)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL193088	=	IC50	nM	3500.0	CHEMBL3117	Homo sapiens	IC50	uM	3.5
	1507058	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL192972	=	IC50	nM	5700.0	CHEMBL3117	Homo sapiens	IC50	uM	5.7
	1507060	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c(N)ccc2c(N(C)c3ccccc3)cc[n+](Cc3cccc(-c4cccc(C[n+]5ccc(N(C)c6ccccc6)c6ccc(N)c(C)c65)c4)c3)c12.[Br-].[Br-]		CHEMBL192379	=	IC50	nM	56800.0	CHEMBL3117	Homo sapiens	IC50	uM	56.8
	1507062	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c(N)ccc2c(N(C)c3ccc(Cl)cc3)cc[n+](Cc3cccc(-c4cccc(C[n+]5ccc(N(C)c6ccc(Cl)cc6)c6ccc(N)c(C)c65)c4)c3)c12.[Br-].[Br-]	Outside typical range	CHEMBL426637	=	IC50	nM	147000.0	CHEMBL3117	Homo sapiens	IC50	uM	147.0
	1507064	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c(N)ccc2c(N(C)c3ccccc3)cc[n+](Cc3ccc(-c4ccc(C[n+]5ccc(N(C)c6ccccc6)c6ccc(N)c(C)c65)cc4)cc3)c12.[Br-].[Br-]		CHEMBL372679	=	IC50	nM	96100.0	CHEMBL3117	Homo sapiens	IC50	uM	96.1
	1507066	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c(N)ccc2c(N(C)c3ccc(Cl)cc3)cc[n+](Cc3ccc(-c4ccc(C[n+]5ccc(N(C)c6ccc(Cl)cc6)c6ccc(N)c(C)c65)cc4)cc3)c12.[Br-].[Br-]		CHEMBL370702	=	IC50	nM	46100.0	CHEMBL3117	Homo sapiens	IC50	uM	46.1
	1507068	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c(N)ccc2c(N(C)c3ccccc3)cc[n+](Cc3ccc(CCc4ccc(C[n+]5ccc(N(C)c6ccccc6)c6ccc(N)c(C)c65)cc4)cc3)c12.[Br-].[Br-]	Outside typical range	CHEMBL193262	=	IC50	nM	133000.0	CHEMBL3117	Homo sapiens	IC50	uM	133.0
	1507070	CHEMBL832433	Ex vivo inhibitory concentration against human choline kinase	B	Cc1c(N)ccc2c(N(C)c3ccc(Cl)cc3)cc[n+](Cc3ccc(CCc4ccc(C[n+]5ccc(N(C)c6ccc(Cl)cc6)c6ccc(N)c(C)c65)cc4)cc3)c12.[Br-].[Br-]		CHEMBL372647	=	IC50	nM	57500.0	CHEMBL3117	Homo sapiens	IC50	uM	57.5
	6182613	CHEMBL1772322	Inhibition of ChoK in HT29 cells using [methyl-14C]choline chloride as substrate after 14 hrs by radiography	B	[Br-].[Br-].c1cc2cc(c1)CNc1cc[n+](cc1)Cc1ccc(cc1)C[n+]1ccc(cc1)NC2		CHEMBL125148	=	IC50	nM	300.0	CHEMBL3117	Homo sapiens	IC50	uM	0.3
	6182620	CHEMBL1772322	Inhibition of ChoK in HT29 cells using [methyl-14C]choline chloride as substrate after 14 hrs by radiography	B	COc1cc2c(cc1OC)CN(c1cc[n+](Cc3ccc(C[n+]4ccc(N5CCCCC5)cc4)cc3)cc1)CC2.[Br-].[Br-]		CHEMBL1771556	=	IC50	nM	8430.0	CHEMBL3117	Homo sapiens	IC50	uM	8.43
	7852203	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	OCC[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CCO)cc6)c(C(F)(F)C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909958	=	IC50	nM	9650.0	CHEMBL3117	Homo sapiens	IC50	uM	9.65
	7852204	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	OCC[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CCO)cc6)c(C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)F)cc1.[I-].[I-]		CHEMBL1909959	=	IC50	nM	23800.0	CHEMBL3117	Homo sapiens	IC50	uM	23.8
	7852205	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	OCC[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CCO)cc6)c(C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909960	>	IC50	nM	20000.0	CHEMBL3117	Homo sapiens	IC50	uM	20.0
	7852206	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	OCC[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CCO)cc6)c(C(F)(F)C(F)(F)C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)C(F)(F)C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909961	=	IC50	nM	17300.0	CHEMBL3117	Homo sapiens	IC50	uM	17.3
	7852207	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CN(C)C(=O)C[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CC(=O)N(C)C)cc6)c(C(F)(F)C(F)(F)C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)C(F)(F)C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909962	=	IC50	nM	4250.0	CHEMBL3117	Homo sapiens	IC50	uM	4.25
	7852208	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CN(C)C(=O)C[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CC(=O)N(C)C)cc6)c(C(F)(F)C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)C(F)(F)F)cc1.[I-].[I-]		CHEMBL1909963	=	IC50	nM	3100.0	CHEMBL3117	Homo sapiens	IC50	uM	3.1
	7852209	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CN(C)C(=O)C[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CC(=O)N(C)C)cc6)c(C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909964	=	IC50	nM	300.0	CHEMBL3117	Homo sapiens	IC50	uM	0.3
	7852210	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CN(C)C(=O)C[n+]1ccc(-c2nc(-c3ccc(-c4ccc(-c5nc(-c6cc[n+](CC(=O)N(C)C)cc6)c(C(F)(F)C(F)(F)F)o5)cc4)cc3)oc2C(F)(F)C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909965	=	IC50	nM	2000.0	CHEMBL3117	Homo sapiens	IC50	uM	2.0
	7852211	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	OCC[n+]1ccc(-c2nc(-c3ccc(C(c4ccc(-c5nc(-c6cc[n+](CCO)cc6)c(C(F)(F)C(F)(F)F)o5)cc4)(C(F)(F)F)C(F)(F)F)cc3)oc2C(F)(F)C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909966	=	IC50	nM	4400.0	CHEMBL3117	Homo sapiens	IC50	uM	4.4
	7852212	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	OCC[n+]1ccc(-c2nc(-c3ccc(C(c4ccc(-c5nc(-c6cc[n+](CCO)cc6)c(C(F)(F)C(F)(F)C(F)(F)F)o5)cc4)(C(F)(F)F)C(F)(F)F)cc3)oc2C(F)(F)C(F)(F)C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909967	=	IC50	nM	13500.0	CHEMBL3117	Homo sapiens	IC50	uM	13.5
	7852213	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	OCC[n+]1ccc(-c2nc(-c3ccc(C(c4ccc(-c5nc(-c6cc[n+](CCO)cc6)c(C(F)(F)C(F)(F)F)o5)cc4)(C(F)(F)F)C(F)(F)F)cc3)oc2C(F)(F)C(F)(F)F)cc1.[I-].[I-]		CHEMBL1909968	=	IC50	nM	4200.0	CHEMBL3117	Homo sapiens	IC50	uM	4.2
	7852214	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CS(=O)(=O)[O-].CS(=O)(=O)[O-].FC(F)(F)C(F)(F)c1oc(-c2ccc(C(c3ccc(-c4nc(-c5cc[n+](CCCl)cc5)c(C(F)(F)C(F)(F)F)o4)cc3)(C(F)(F)F)C(F)(F)F)cc2)nc1-c1cc[n+](CCCl)cc1		CHEMBL1909969	=	IC50	nM	14200.0	CHEMBL3117	Homo sapiens	IC50	uM	14.2
	7852215	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CS(=O)(=O)[O-].CS(=O)(=O)[O-].FC(F)(F)c1oc(-c2ccc(C(c3ccc(-c4nc(-c5cc[n+](CCCl)cc5)c(C(F)(F)F)o4)cc3)(C(F)(F)F)C(F)(F)F)cc2)nc1-c1cc[n+](CCCl)cc1		CHEMBL1909970	=	IC50	nM	12500.0	CHEMBL3117	Homo sapiens	IC50	uM	12.5
	7852216	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CS(=O)(=O)[O-].CS(=O)(=O)[O-].FC(F)(F)C(F)(F)C(F)(F)c1oc(-c2ccc(C(c3ccc(-c4nc(-c5cc[n+](CCCl)cc5)c(C(F)(F)C(F)(F)C(F)(F)F)o4)cc3)(C(F)(F)F)C(F)(F)F)cc2)nc1-c1cc[n+](CCCl)cc1		CHEMBL1909971	=	IC50	nM	11600.0	CHEMBL3117	Homo sapiens	IC50	uM	11.6
	7852217	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CN(C)C(=O)C[n+]1ccc(-c2nc(-c3ccc(C(c4ccc(-c5nc(-c6cc[n+](CC(=O)N(C)C)cc6)c(C(F)(F)F)o5)cc4)(C(F)(F)F)C(F)(F)F)cc3)oc2C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909972	=	IC50	nM	6150.0	CHEMBL3117	Homo sapiens	IC50	uM	6.15
	7852218	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CN(C)C(=O)C[n+]1ccc(-c2nc(-c3ccc(-c4nc(-c5cc[n+](CC(=O)N(C)C)cc5)c(C(F)(F)F)o4)cc3)oc2C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909973	=	IC50	nM	1350.0	CHEMBL3117	Homo sapiens	IC50	uM	1.35
	7852219	CHEMBL1912789	Inhibition of recombinant human Choline kinase alpha using [methyl-14C]choline chloride as substrate after 30 mins by autoradiography	B	CN(C)C(=O)C[n+]1ccc(-c2nc(-c3ccc(-c4nc(-c5cc[n+](CC(=O)N(C)C)cc5)c(C(F)(F)C(F)(F)F)o4)cc3)oc2C(F)(F)C(F)(F)F)cc1.[Cl-].[Cl-]		CHEMBL1909974	=	IC50	nM	15000.0	CHEMBL3117	Homo sapiens	IC50	uM	15.0
	13918296	CHEMBL3117184	Binding affinity to human CK-alpha1 by tryptophan fluorescence spectroscopic analysis	B	CN(C)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL3112877	=	Kd	nM	620.0	CHEMBL3117	Homo sapiens	Kd	uM	0.62
	13918297	CHEMBL3117184	Binding affinity to human CK-alpha1 by tryptophan fluorescence spectroscopic analysis	B	CN(C)c1cc[n+](Cc2ccc(CCCCc3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL3112879	=	Kd	nM	110.0	CHEMBL3117	Homo sapiens	Kd	uM	0.11
	13918298	CHEMBL3117184	Binding affinity to human CK-alpha1 by tryptophan fluorescence spectroscopic analysis	B	CN(C)c1cc[n+](Cc2ccc(CCc3ccc(C[n+]4ccc(N5CCCC5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL3112870	=	Kd	nM	400.0	CHEMBL3117	Homo sapiens	Kd	uM	0.4
	14536878	CHEMBL3227789	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL3219756	=	EC50	nM	520.0	CHEMBL3117	Homo sapiens	EC50	uM	0.52
	14536879	CHEMBL3227789	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL228000	=	EC50	nM	1300.0	CHEMBL3117	Homo sapiens	EC50	uM	1.3
	14536880	CHEMBL3227786	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate at 2.4 +/-1 uM incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL3219756	>	Inhibition	%	75.0	CHEMBL3117	Homo sapiens	INH	%	75.0
	14536881	CHEMBL3227786	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate at 2.4 +/-1 uM incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL228000	>	Inhibition	%	75.0	CHEMBL3117	Homo sapiens	INH	%	75.0
	14536882	CHEMBL3227787	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate at 6.5 +/-4 uM incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL3219756	>	Inhibition	%	75.0	CHEMBL3117	Homo sapiens	INH	%	75.0
	14536883	CHEMBL3227787	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate at 6.5 +/-4 uM incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL228000	>	Inhibition	%	75.0	CHEMBL3117	Homo sapiens	INH	%	75.0
Dose-dependent effect	14536884	CHEMBL3227789	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL3219756		Inhibition	%		CHEMBL3117	Homo sapiens	INH		
Dose-dependent effect	14536885	CHEMBL3227789	Inhibition of CHKA in human HCT116 cells assessed as [3H]phosphocholine formation using [3H]choline chloride as substrate incubated for 1 hr prior to substrate addition measured after 1 hr by scintillation counting analysis	B	CN(C)c1cc[n+](CCCCCCCCCCCC[n+]2ccc(N(C)C)cc2)cc1.[Br-].[Br-]		CHEMBL228000		Inhibition	%		CHEMBL3117	Homo sapiens	INH		
	16376974	CHEMBL3734544	Inhibition of recombinant CK-alpha (unknown origin) expressed in Escherichia coli BL21 (DE3) cells	B	CCOc1ccc(-c2nnc(SCC(=O)Nc3cc(C)cc(C)c3)[nH]2)cc1		CHEMBL3731984	=	IC50	nM	20000.0	CHEMBL3117	Homo sapiens	IC50	uM	20.0
	16376975	CHEMBL3734544	Inhibition of recombinant CK-alpha (unknown origin) expressed in Escherichia coli BL21 (DE3) cells	B	CCOc1ccc(-c2nnc(SCC(=O)N(C)c3cc(C)cc(C)c3)[nH]2)cc1		CHEMBL3731257	=	IC50	nM	30000.0	CHEMBL3117	Homo sapiens	IC50	uM	30.0
	16376976	CHEMBL3734544	Inhibition of recombinant CK-alpha (unknown origin) expressed in Escherichia coli BL21 (DE3) cells	B	CCOc1ccc(-c2nnc(SCC(=O)Nc3cc(OC)cc(OC)c3)[nH]2)cc1		CHEMBL3728842	=	IC50	nM	18000.0	CHEMBL3117	Homo sapiens	IC50	uM	18.0
	16376977	CHEMBL3734544	Inhibition of recombinant CK-alpha (unknown origin) expressed in Escherichia coli BL21 (DE3) cells	B	CCOc1ccc(-c2nnc(SCC(=O)Nc3cccc(OC)c3)[nH]2)cc1		CHEMBL3730963	=	IC50	nM	50000.0	CHEMBL3117	Homo sapiens	IC50	uM	50.0
	16376978	CHEMBL3734544	Inhibition of recombinant CK-alpha (unknown origin) expressed in Escherichia coli BL21 (DE3) cells	B	CCOc1ccc(-c2nnc(SCC(=O)NC3CC(C)(C)NC(C)(C)C3)[nH]2)cc1		CHEMBL3732503	>	IC50	nM	100000.0	CHEMBL3117	Homo sapiens	IC50	uM	100.0
	16480189	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(CN)cc2)CC1		CHEMBL3763993	=	Kd	nM	132000.0	CHEMBL3117	Homo sapiens	Kd	uM	132.0
	16480190	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(CN)cc2)CC1		CHEMBL3763993	=	IC50	nM	87000.0	CHEMBL3117	Homo sapiens	IC50	uM	87.0
	16480191	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(c2ccc(CO)cc2)CC1		CHEMBL3765610	=	Kd	nM	194000.0	CHEMBL3117	Homo sapiens	Kd	uM	194.0
	16480192	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(c2ccc(CO)cc2)CC1		CHEMBL3765610	>	IC50	nM	2000000.0	CHEMBL3117	Homo sapiens	IC50	uM	2000.0
Active	16480193	CHEMBL3766476	Reversible binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) ChoKalpha1 by STD NMR analysis	B	Cc1cc(O)cc(C)c1C#N		CHEMBL3765491		Activity			CHEMBL3117	Homo sapiens	Activity		
	16480195	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	O=C(N1CCCCCC1)N1CCNCC1		CHEMBL3763196	>	IC50	nM	300000.0	CHEMBL3117	Homo sapiens	IC50	mM	0.3
	16480196	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	O=C(N1CCCCCC1)N1CCNCC1		CHEMBL3763196	=	Kd	nM	340000.0	CHEMBL3117	Homo sapiens	Kd	mM	0.34
	16480198	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	Nc1cc(C(F)(F)F)ncn1		CHEMBL3764475	>	IC50	nM	300000.0	CHEMBL3117	Homo sapiens	IC50	mM	0.3
	16480199	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	Nc1cc(C(F)(F)F)ncn1		CHEMBL3764475	=	Kd	nM	630000.0	CHEMBL3117	Homo sapiens	Kd	mM	0.63
	16480201	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCNCC(Cc2ccc3ncccc3c2)C1		CHEMBL3764395	=	IC50	nM	17200.0	CHEMBL3117	Homo sapiens	IC50	uM	17.2
	16480202	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCNCC(Cc2ccc3ncccc3c2)C1		CHEMBL3764395	=	Kd	nM	7000.0	CHEMBL3117	Homo sapiens	Kd	uM	7.0
	16480203	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc3ncccc3c2)CC1		CHEMBL3765077	=	IC50	nM	3900.0	CHEMBL3117	Homo sapiens	IC50	uM	3.9
	16480204	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc3ncccc3c2)CC1		CHEMBL3765077	=	Kd	nM	4000.0	CHEMBL3117	Homo sapiens	Kd	uM	4.0
	16480205	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc3ccccc3c2)CC1		CHEMBL3765650	=	IC50	nM	2600.0	CHEMBL3117	Homo sapiens	IC50	uM	2.6
	16480206	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc3ccccc3c2)CC1		CHEMBL3765650	=	Kd	nM	4300.0	CHEMBL3117	Homo sapiens	Kd	uM	4.3
	16480207	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccccc3)cc2)CC1		CHEMBL3763340	=	IC50	nM	1480.0	CHEMBL3117	Homo sapiens	IC50	nM	1480.0
	16480208	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccccc3)cc2)CC1		CHEMBL3763340	=	Kd	nM	3700.0	CHEMBL3117	Homo sapiens	Kd	nM	3700.0
	16480209	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(N4CCN(C)CC4)cc3)cc2)CC1		CHEMBL3764898	=	IC50	nM	1300.0	CHEMBL3117	Homo sapiens	IC50	nM	1300.0
	16480210	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(N4CCN(C)CC4)cc3)cc2)CC1		CHEMBL3764898	=	Kd	nM	769.0	CHEMBL3117	Homo sapiens	Kd	nM	769.0
	16480211	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	COC(=O)c1ccc(-c2ccc(CN3CCCN(C)CC3)cc2)cc1		CHEMBL3764904	=	IC50	nM	4950.0	CHEMBL3117	Homo sapiens	IC50	nM	4950.0
	16480212	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	COC(=O)c1ccc(-c2ccc(CN3CCCN(C)CC3)cc2)cc1		CHEMBL3764904	=	Kd	nM	2400.0	CHEMBL3117	Homo sapiens	Kd	nM	2400.0
	16480213	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	COc1ccc(-c2ccc(CN3CCCN(C)CC3)cc2)cc1		CHEMBL3764767	=	IC50	nM	1430.0	CHEMBL3117	Homo sapiens	IC50	nM	1430.0
	16480214	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	COc1ccc(-c2ccc(CN3CCCN(C)CC3)cc2)cc1		CHEMBL3764767	=	Kd	nM	3800.0	CHEMBL3117	Homo sapiens	Kd	nM	3800.0
	16480215	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)CC1		CHEMBL3765567	=	IC50	nM	2600.0	CHEMBL3117	Homo sapiens	IC50	nM	2600.0
	16480216	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)CC1		CHEMBL3765567	=	Kd	nM	4000.0	CHEMBL3117	Homo sapiens	Kd	nM	4000.0
	16480217	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(C(=O)N4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3765239	=	IC50	nM	251.0	CHEMBL3117	Homo sapiens	IC50	nM	251.0
	16480218	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(C(=O)N4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3765239	=	Kd	nM	195.0	CHEMBL3117	Homo sapiens	Kd	nM	195.0
	16480219	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3763801	=	IC50	nM	457.0	CHEMBL3117	Homo sapiens	IC50	nM	457.0
	16480220	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3763801	=	Kd	nM	382.0	CHEMBL3117	Homo sapiens	Kd	nM	382.0
	16480221	CHEMBL3769132	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as association rate constant by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3763801	=	Ka	/mM/s	94.0	CHEMBL3117	Homo sapiens	Ka	/mM/s	94.0
	16480231	CHEMBL3766469	Inhibition of ChoKalpha in human MDA-MB-468 cells assessed as reduction in phosphocholine level after 24 hrs by NMR analysis	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3763801	=	IC50	nM	2000.0	CHEMBL3117	Homo sapiens	IC50	uM	2.0
Dose-dependent effect	16480232	CHEMBL3766469	Inhibition of ChoKalpha in human MDA-MB-468 cells assessed as reduction in phosphocholine level after 24 hrs by NMR analysis	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3763801		Inhibition	%		CHEMBL3117	Homo sapiens	INH		
	16480233	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)cc2)CC1		CHEMBL3763540	=	IC50	nM	66.0	CHEMBL3117	Homo sapiens	IC50	nM	66.0
	16480234	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)cc2)CC1		CHEMBL3763540	=	Kd	nM	10.0	CHEMBL3117	Homo sapiens	Kd	nM	10.0
	16480235	CHEMBL3769132	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as association rate constant by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)cc2)CC1		CHEMBL3763540	=	Ka	/mM/s	676.0	CHEMBL3117	Homo sapiens	Ka	/mM/s	676.0
	16480236	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(F)c3F)cc2)CC1		CHEMBL3764278	=	IC50	nM	233.0	CHEMBL3117	Homo sapiens	IC50	nM	233.0
	16480237	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(F)c3F)cc2)CC1		CHEMBL3764278	=	Kd	nM	21.0	CHEMBL3117	Homo sapiens	Kd	nM	21.0
	16480238	CHEMBL3769132	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as association rate constant by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(F)c3F)cc2)CC1		CHEMBL3764278	=	Ka	/mM/s	718.0	CHEMBL3117	Homo sapiens	Ka	/mM/s	718.0
	16480239	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)c(F)c2)CC1		CHEMBL3763931	=	IC50	nM	85.0	CHEMBL3117	Homo sapiens	IC50	nM	85.0
	16480240	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)c(F)c2)CC1		CHEMBL3763931	=	Kd	nM	99.0	CHEMBL3117	Homo sapiens	Kd	nM	99.0
	16480241	CHEMBL3769132	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as association rate constant by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)c(F)c2)CC1		CHEMBL3763931	=	Ka	/mM/s	112.0	CHEMBL3117	Homo sapiens	Ka	/mM/s	112.0
	16480251	CHEMBL3766470	Inhibition of ChoKalpha in human MDA-MB-415 cells assessed as reduction in phosphocholine level after 24 hrs by NMR analysis	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)c(F)c2)CC1		CHEMBL3763931	=	IC50	nM	750.0	CHEMBL3117	Homo sapiens	IC50	uM	0.75
	16480252	CHEMBL3766470	Inhibition of ChoKalpha in human MDA-MB-415 cells assessed as reduction in phosphocholine level after 24 hrs by NMR analysis	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)c(F)c2)CC1		CHEMBL3763931	=	Inhibition	%	80.0	CHEMBL3117	Homo sapiens	INH	%	80.0
Dose-dependent effect	16480253	CHEMBL3766470	Inhibition of ChoKalpha in human MDA-MB-415 cells assessed as reduction in phosphocholine level after 24 hrs by NMR analysis	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)c(F)c2)CC1		CHEMBL3763931		Inhibition	%		CHEMBL3117	Homo sapiens	INH		
	16480255	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(Cl)c3)cc2)CC1		CHEMBL3763792	=	IC50	nM	268.0	CHEMBL3117	Homo sapiens	IC50	nM	268.0
	16480256	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(Cl)c3)cc2)CC1		CHEMBL3763792	=	Kd	nM	88.0	CHEMBL3117	Homo sapiens	Kd	nM	88.0
	16480257	CHEMBL3769132	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as association rate constant by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(Cl)c3)cc2)CC1		CHEMBL3763792	=	Ka	/mM/s	235.0	CHEMBL3117	Homo sapiens	Ka	/mM/s	235.0
	16480258	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3F)cc2)CC1		CHEMBL3763982	=	IC50	nM	165.0	CHEMBL3117	Homo sapiens	IC50	nM	165.0
	16480259	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3F)cc2)CC1		CHEMBL3763982	=	Kd	nM	211.0	CHEMBL3117	Homo sapiens	Kd	nM	211.0
	16480260	CHEMBL3769132	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as association rate constant by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3F)cc2)CC1		CHEMBL3763982	=	Ka	/mM/s	93.0	CHEMBL3117	Homo sapiens	Ka	/mM/s	93.0
	16480261	CHEMBL3769133	Inhibition of human N-terminal truncated ChoKalpha1 (75 to 457 residues) using choline chloride as substrate measured over 10 to 30 mins by coupled ATP regeneration assay	B	CN1CCCN(Cc2ccc(-c3cc(F)c(CN4CCCN(C)CC4)c(F)c3)cc2)CC1		CHEMBL3763453	=	IC50	nM	255.0	CHEMBL3117	Homo sapiens	IC50	nM	255.0
	16480262	CHEMBL3769127	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3cc(F)c(CN4CCCN(C)CC4)c(F)c3)cc2)CC1		CHEMBL3763453	=	Kd	nM	259.0	CHEMBL3117	Homo sapiens	Kd	nM	259.0
	16480263	CHEMBL3769132	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as association rate constant by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3cc(F)c(CN4CCCN(C)CC4)c(F)c3)cc2)CC1		CHEMBL3763453	=	Ka	/mM/s	125.0	CHEMBL3117	Homo sapiens	Ka	/mM/s	125.0
	16480264	CHEMBL3766475	Inhibition of recombinant human ChoKalpha using choline as substrate by ultraviolet spectroscopic assay	B	O[C@](CCc1ccccc1OC1CCOCC1)(c1ccccc1)C1CN2CCC1CC2		CHEMBL3765554	=	IC50	nM	20.0	CHEMBL3117	Homo sapiens	IC50	nM	20.0
	16480269	CHEMBL3769131	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as ligand residence time by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3)cc2)CC1		CHEMBL3763801	=	TIME	hr	0.007778	CHEMBL3117	Homo sapiens	Time	s	28.0
	16480270	CHEMBL3769131	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as ligand residence time by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)cc2)CC1		CHEMBL3763540	=	TIME	hr	0.03972	CHEMBL3117	Homo sapiens	Time	s	143.0
	16480271	CHEMBL3769131	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as ligand residence time by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(F)c3F)cc2)CC1		CHEMBL3764278	=	TIME	hr	0.01833	CHEMBL3117	Homo sapiens	Time	s	66.0
	16480272	CHEMBL3769131	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as ligand residence time by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3C#N)c(F)c2)CC1		CHEMBL3763931	=	TIME	hr	0.025	CHEMBL3117	Homo sapiens	Time	s	90.0
	16480273	CHEMBL3769131	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as ligand residence time by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)c(Cl)c3)cc2)CC1		CHEMBL3763792	=	TIME	hr	0.01333	CHEMBL3117	Homo sapiens	Time	s	48.0
	16480274	CHEMBL3769131	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as ligand residence time by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3ccc(CN4CCCN(C)CC4)cc3F)cc2)CC1		CHEMBL3763982	=	TIME	hr	0.01417	CHEMBL3117	Homo sapiens	Time	s	51.0
	16480275	CHEMBL3769131	Binding affinity to human N-terminal truncated ChoKalpha1 (75 to 457 residues) assessed as ligand residence time by surface plasmon resonance assay	B	CN1CCCN(Cc2ccc(-c3cc(F)c(CN4CCCN(C)CC4)c(F)c3)cc2)CC1		CHEMBL3763453	=	TIME	hr	0.008611	CHEMBL3117	Homo sapiens	Time	s	31.0
	18069862	CHEMBL4015086	Inhibition of human CHKalpha (1 to 457 residues) by ADP Glo HTS assay	B	O=C(c1cc([C@H]2CCCN2c2cc(F)cc(F)c2)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCOCC1		CHEMBL4060768	>	IC50	nM	50000.0	CHEMBL3117	Homo sapiens	IC50	uM	50.0
Not Active	18161868	CHEMBL4035998	Inhibition of human CHKalpha (1 to 457 residues) at 50 uM by ADP Glo HTS assay	B	CNC(=O)c1nc(-c2nc(-c3cnc4ccccn34)c(C)nc2N)n(C)n1		CHEMBL4072637		Inhibition	%		CHEMBL3117	Homo sapiens	INH		
Not Determined	18301555	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(C)c1cc[n+](Cc2ccc(CCCCc3ccc(C[n+]4ccc(N5CCCC5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL3112871		IC50			CHEMBL3117	Homo sapiens	IC50		
Not Determined	18301556	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(C)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N5CCCC5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL3112869		IC50			CHEMBL3117	Homo sapiens	IC50		
	18301557	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(-c3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL192986	=	IC50	nM	1920.0	CHEMBL3117	Homo sapiens	IC50	uM	1.92
	18301558	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(C)c1cc[n+](Cc2ccc(CCCCc3ccc(C[n+]4ccc(N(C)C)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL1771545	=	IC50	nM	780.0	CHEMBL3117	Homo sapiens	IC50	uM	0.78
	18301559	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccc(OCCOc4ccc(C[n+]5ccc(N6CCCC6)c6ccc(Cl)cc65)cc4)cc3)c2c1.[Br-].[Br-]		CHEMBL4128522	=	IC50	nM	920.0	CHEMBL3117	Homo sapiens	IC50	uM	0.92
	18301560	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccc(OCCOc4ccc(C[n+]5ccc(N6CCCCCC6)c6ccc(Cl)cc65)cc4)cc3)c2c1.[Br-].[Br-]		CHEMBL4129777	=	IC50	nM	2020.0	CHEMBL3117	Homo sapiens	IC50	uM	2.02
	18301561	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	[Br-].[Br-].c1ccc2c(c1)c(N1CCCCCC1)cc[n+]2Cc1ccc(OCCOc2ccc(C[n+]3ccc(N4CCCCCC4)c4ccccc43)cc2)cc1		CHEMBL4125997	=	IC50	nM	1660.0	CHEMBL3117	Homo sapiens	IC50	uM	1.66
	18301562	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(OCCOc3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL4127055	=	IC50	nM	16220.0	CHEMBL3117	Homo sapiens	IC50	uM	16.22
	18301563	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(OCCOc3ccc(C[n+]4ccc(N(C)c5ccccc5)c5ccc(Cl)cc54)cc3)cc2)c2cc(Cl)ccc12.[Br-].[Br-]		CHEMBL4126001	=	IC50	nM	2790.0	CHEMBL3117	Homo sapiens	IC50	uM	2.79
	18301564	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(OCCOc3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL4127381	=	IC50	nM	3270.0	CHEMBL3117	Homo sapiens	IC50	uM	3.27
	18301565	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(OCCOc3ccc(C[n+]4ccc(N(C)c5ccccc5)c5ccccc54)cc3)cc2)c2ccccc12.[Br-].[Br-]		CHEMBL4126529	=	IC50	nM	6850.0	CHEMBL3117	Homo sapiens	IC50	uM	6.85
	18301566	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	OC1C[N+]2(Cc3ccc(OCCOc4ccc(C[N+]56CCC(CC5)C(O)C6)cc4)cc3)CCC1CC2.[Br-].[Br-]		CHEMBL4126415	=	IC50	nM	9510.0	CHEMBL3117	Homo sapiens	IC50	uM	9.51
	18301567	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	[Br-].[Br-].c1cc(OCCOc2ccc(C[N+]34CCC(CC3)CC4)cc2)ccc1C[N+]12CCC(CC1)CC2		CHEMBL4128482	=	IC50	nM	37540.0	CHEMBL3117	Homo sapiens	IC50	uM	37.54
	18301568	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(OCCOc3ccc(C[n+]4ccc(N(C)c5ccc(Cl)cc5)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL4129845	=	IC50	nM	1630.0	CHEMBL3117	Homo sapiens	IC50	uM	1.63
	18301569	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	[Br-].[Br-].c1cc(OCCOc2ccc(C[n+]3ccc(N4CCCC4)cc3)cc2)ccc1C[n+]1ccc(N2CCCC2)cc1		CHEMBL4127500	=	IC50	nM	9560.0	CHEMBL3117	Homo sapiens	IC50	uM	9.56
	18301570	CHEMBL4124880	Inhibition of human choline kinase alpha1 using [methyl-14C]choline as substrate assessed as reduction in rate of incorporation of 14C from [methyl-14C]choline into phosphocholine preincubated for 5 mins followed by substrate addition measured after 10 mins by scintillation counting	B	CN(C)c1cc[n+](Cc2ccc(OCCOc3ccc(C[n+]4ccc(N(C)C)cc4)cc3)cc2)cc1.[Br-].[Br-]		CHEMBL4128899	=	IC50	nM	1000.0	CHEMBL3117	Homo sapiens	IC50	uM	1.0
	18665549	CHEMBL4233303	Inhibition of ChoK (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL3117	Homo sapiens	IC50	nM	10000.0
	18674601	CHEMBL4235334	Inhibition of ChoK (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL3117	Homo sapiens	Ki	nM	10000.0
	18674602	CHEMBL4235334	Inhibition of ChoK (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	10000.0	CHEMBL3117	Homo sapiens	Ki	nM	10000.0
Not Determined	18674603	CHEMBL4235334	Inhibition of ChoK (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL3117	Homo sapiens	Ki		
	19474688	CHEMBL4479377	Inhibition of choline kinase alpha (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL3117	Homo sapiens	pIC50		5.0
	22799987	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	CN(C)c1cc[n+](Cc2ccccc2)cc1.[Br-]		CHEMBL1508421	=	Kd	nM	14000.0	CHEMBL3117	Homo sapiens	Kd	uM	14.0
	22799988	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	[Br-].c1ccc(C[n+]2ccc(N3CCCC3)cc2)cc1		CHEMBL1771557	=	Kd	nM	24000.0	CHEMBL3117	Homo sapiens	Kd	uM	24.0
	22799989	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccccc3)c2c1.[Br-]		CHEMBL4763249	=	Kd	nM	400.0	CHEMBL3117	Homo sapiens	Kd	uM	0.4
	22799990	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	CN(c1ccccc1)c1cc[n+](Cc2ccccc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4756022	=	Kd	nM	890.0	CHEMBL3117	Homo sapiens	Kd	uM	0.89
	22799991	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	CN(C)c1cc[n+](Cc2ccc(-c3ccccc3)cc2)cc1.[Br-]		CHEMBL4755703	=	Kd	nM	1700.0	CHEMBL3117	Homo sapiens	Kd	uM	1.7
	22799992	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	[Br-].c1ccc(-c2ccc(C[n+]3ccc(N4CCCC4)cc3)cc2)cc1		CHEMBL4748826	=	Kd	nM	670.0	CHEMBL3117	Homo sapiens	Kd	uM	0.67
	22799993	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccc(-c4ccccc4)cc3)c2c1.[Br-]		CHEMBL4784458	=	Kd	nM	370.0	CHEMBL3117	Homo sapiens	Kd	uM	0.37
	22799994	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(-c3ccccc3)cc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4747352	=	Kd	nM	185.0	CHEMBL3117	Homo sapiens	Kd	uM	0.185
	22799995	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	CN(C)c1ccncc1		CHEMBL3561645	=	Kd	nM	35000.0	CHEMBL3117	Homo sapiens	Kd	uM	35.0
	22799996	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	c1cc(N2CCCC2)ccn1		CHEMBL4754833	=	Kd	nM	49000.0	CHEMBL3117	Homo sapiens	Kd	uM	49.0
	22799997	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	Clc1ccc2c(N3CCCCCC3)ccnc2c1		CHEMBL4796843	=	Kd	nM	45000.0	CHEMBL3117	Homo sapiens	Kd	uM	45.0
	22799998	CHEMBL4711237	Binding affinity to human CKalpha1 assessed as dissociation constant by spectroflurometry	B	CN(c1ccccc1)c1ccnc2cc(Cl)ccc12		CHEMBL4776753	=	Kd	nM	82000.0	CHEMBL3117	Homo sapiens	Kd	uM	82.0
	22800007	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	[Br-].c1ccc(C[n+]2ccc(N3CCCC3)cc2)cc1		CHEMBL1771557	=	Inhibition	%	11.08	CHEMBL3117	Homo sapiens	INH	%	11.08
	22800008	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccccc3)c2c1.[Br-]		CHEMBL4755424	=	Inhibition	%	31.54	CHEMBL3117	Homo sapiens	INH	%	31.54
	22800009	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccccc3)c2c1.[Br-]		CHEMBL4763249	=	Inhibition	%	35.81	CHEMBL3117	Homo sapiens	INH	%	35.81
	22800010	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccccc1)c1cc[n+](Cc2ccccc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4756022	=	Inhibition	%	23.08	CHEMBL3117	Homo sapiens	INH	%	23.08
	22800011	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(C)c1cc[n+](Cc2ccc(C(F)(F)F)cc2)cc1.[Br-]		CHEMBL4795134	=	Inhibition	%	25.42	CHEMBL3117	Homo sapiens	INH	%	25.42
	22800012	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	FC(F)(F)c1ccc(C[N+]23CCC(CC2)CC3)cc1.[Br-]		CHEMBL4785994	=	Inhibition	%	8.07	CHEMBL3117	Homo sapiens	INH	%	8.07
	22800013	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	FC(F)(F)c1ccc(C[n+]2ccc(N3CCCCCC3)c3ccc(Cl)cc32)cc1.[Br-]		CHEMBL4758159	=	Inhibition	%	34.74	CHEMBL3117	Homo sapiens	INH	%	34.74
	22800014	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(C(F)(F)F)cc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4747031	=	Inhibition	%	10.41	CHEMBL3117	Homo sapiens	INH	%	10.41
	22800015	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(C)c1cc[n+](Cc2ccc(-c3ccccc3)cc2)cc1.[Br-]		CHEMBL4755703	=	Inhibition	%	18.85	CHEMBL3117	Homo sapiens	INH	%	18.85
	22800016	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	[Br-].c1ccc(-c2ccc(C[N+]34CCC(CC3)CC4)cc2)cc1		CHEMBL4780767	=	Inhibition	%	26.57	CHEMBL3117	Homo sapiens	INH	%	26.57
	22800017	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	OC1C[N+]2(Cc3ccc(-c4ccccc4)cc3)CCC1CC2.[Br-]		CHEMBL4785500	=	Inhibition	%	45.59	CHEMBL3117	Homo sapiens	INH	%	45.59
	22800018	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccc(-c4ccccc4)cc3)c2c1.[Br-]		CHEMBL4798511	=	Inhibition	%	36.87	CHEMBL3117	Homo sapiens	INH	%	36.87
	22800019	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccc(-c4ccccc4)cc3)c2c1.[Br-]		CHEMBL4784458	=	Inhibition	%	74.39	CHEMBL3117	Homo sapiens	INH	%	74.39
	22800020	CHEMBL4711240	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 10 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(-c3ccccc3)cc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4747352	=	Inhibition	%	38.61	CHEMBL3117	Homo sapiens	INH	%	38.61
	22800021	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(C)c1cc[n+](Cc2ccccc2)cc1.[Br-]		CHEMBL1508421	=	Inhibition	%	37.2	CHEMBL3117	Homo sapiens	INH	%	37.2
	22800022	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	[Br-].c1ccc(C[n+]2ccc(N3CCCC3)cc2)cc1		CHEMBL1771557	=	Inhibition	%	19.57	CHEMBL3117	Homo sapiens	INH	%	19.57
	22800023	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccccc3)c2c1.[Br-]		CHEMBL4755424	=	Inhibition	%	35.02	CHEMBL3117	Homo sapiens	INH	%	35.02
	22800024	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccccc3)c2c1.[Br-]		CHEMBL4763249	=	Inhibition	%	27.53	CHEMBL3117	Homo sapiens	INH	%	27.53
	22800025	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccccc1)c1cc[n+](Cc2ccccc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4756022	=	Inhibition	%	28.38	CHEMBL3117	Homo sapiens	INH	%	28.38
	22800026	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(C)c1cc[n+](Cc2ccc(C(F)(F)F)cc2)cc1.[Br-]		CHEMBL4795134	=	Inhibition	%	33.53	CHEMBL3117	Homo sapiens	INH	%	33.53
	22800027	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	FC(F)(F)c1ccc(C[N+]23CCC(CC2)CC3)cc1.[Br-]		CHEMBL4785994	=	Inhibition	%	24.67	CHEMBL3117	Homo sapiens	INH	%	24.67
	22800028	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	FC(F)(F)c1ccc(C[n+]2ccc(N3CCCC3)c3ccc(Cl)cc32)cc1.[Br-]		CHEMBL4743873	=	Inhibition	%	24.92	CHEMBL3117	Homo sapiens	INH	%	24.92
	22800029	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	FC(F)(F)c1ccc(C[n+]2ccc(N3CCCCCC3)c3ccc(Cl)cc32)cc1.[Br-]		CHEMBL4758159	=	Inhibition	%	52.68	CHEMBL3117	Homo sapiens	INH	%	52.68
	22800030	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccc(Cl)cc1)c1cc[n+](Cc2ccc(C(F)(F)F)cc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4747031	=	Inhibition	%	14.5	CHEMBL3117	Homo sapiens	INH	%	14.5
	22800031	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(C)c1cc[n+](Cc2ccc(-c3ccccc3)cc2)cc1.[Br-]		CHEMBL4755703	=	Inhibition	%	26.45	CHEMBL3117	Homo sapiens	INH	%	26.45
	22800032	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	[Br-].c1ccc(-c2ccc(C[n+]3ccc(N4CCCC4)cc3)cc2)cc1		CHEMBL4748826	=	Inhibition	%	28.03	CHEMBL3117	Homo sapiens	INH	%	28.03
	22800033	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	[Br-].c1ccc(-c2ccc(C[N+]34CCC(CC3)CC4)cc2)cc1		CHEMBL4780767	=	Inhibition	%	30.19	CHEMBL3117	Homo sapiens	INH	%	30.19
	22800034	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	OC1C[N+]2(Cc3ccc(-c4ccccc4)cc3)CCC1CC2.[Br-]		CHEMBL4785500	=	Inhibition	%	53.03	CHEMBL3117	Homo sapiens	INH	%	53.03
	22800035	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccc(-c4ccccc4)cc3)c2c1.[Br-]		CHEMBL4798511	=	Inhibition	%	46.28	CHEMBL3117	Homo sapiens	INH	%	46.28
	22800036	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccc(-c4ccccc4)cc3)c2c1.[Br-]		CHEMBL4784458	=	Inhibition	%	94.44	CHEMBL3117	Homo sapiens	INH	%	94.44
	22800037	CHEMBL4711241	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 30 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(-c3ccccc3)cc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4747352	=	Inhibition	%	76.0	CHEMBL3117	Homo sapiens	INH	%	76.0
	22800038	CHEMBL4711242	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 50 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	[Br-].c1ccc(C[n+]2ccc(N3CCCC3)cc2)cc1		CHEMBL1771557	=	Inhibition	%	27.84	CHEMBL3117	Homo sapiens	INH	%	27.84
	22800039	CHEMBL4711242	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 50 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccccc3)c2c1.[Br-]		CHEMBL4763249	=	Inhibition	%	38.7	CHEMBL3117	Homo sapiens	INH	%	38.7
	22800040	CHEMBL4711242	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine at 50 uM using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccccc1)c1cc[n+](Cc2ccccc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4756022	=	Inhibition	%	18.58	CHEMBL3117	Homo sapiens	INH	%	18.58
	22800041	CHEMBL4711243	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	Clc1ccc2c(N3CCCCCC3)cc[n+](Cc3ccc(-c4ccccc4)cc3)c2c1.[Br-]		CHEMBL4784458	=	IC50	nM	6740.0	CHEMBL3117	Homo sapiens	IC50	uM	6.74
	22800042	CHEMBL4711243	Inhibition of human CKalpha1 assessed as reduction in 14C incorporation from [methyl-14C]choline to phosphatidylcholine using [methyl-14C]choline as substrate preincubated for 5 mins in presence of ATP and MgCl2 followed by substrate addition and measured after 10 mins by liquid scintillation counting method relative to control	B	CN(c1ccccc1)c1cc[n+](Cc2ccc(-c3ccccc3)cc2)c2cc(Cl)ccc12.[Br-]		CHEMBL4747352	=	IC50	nM	12550.0	CHEMBL3117	Homo sapiens	IC50	uM	12.55
